Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells

Eitemau Tebyg

• EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro
  gan: James, Sharon Y, et al.
  Cyhoeddwyd: (1998)
• Metabolism of the vitamin D(3) analogue EB1089 alters receptor complex formation and reduces promoter selectivity
  gan: Quack, Marcus, et al.
  Cyhoeddwyd: (1998)
• A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.
  gan: Gulliford, T., et al.
  Cyhoeddwyd: (1998)
• A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer
  gan: Evans, T R J, et al.
  Cyhoeddwyd: (2002)
• A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
  gan: Haq, M, et al.
  Cyhoeddwyd: (1993)